Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6453]

Cancer cell vulnerability points to potential treatment path for aggressive disease

Cancer cell vulnerability points to potential treatment path for aggressive disease

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer

Study finds combination therapy suppresses pancreatic tumour growth in mice

Study finds combination therapy suppresses pancreatic tumour growth in mice

Acid reflux disease may increase risk of cancers of the larynx and oesophagus

Acid reflux disease may increase risk of cancers of the larynx and oesophagus

Penn-developed CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

Penn-developed CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

TGen-led study confirms cell-free DNA in urine as potential method for cancer detection

TGen-led study confirms cell-free DNA in urine as potential method for cancer detection

Proton therapy induces biologic response to attack treatment-resistant cancers

Proton therapy induces biologic response to attack treatment-resistant cancers

Research reveals never-before-seen antibody binding and informing liver cancer and antibody design

Research reveals never-before-seen antibody binding and informing liver cancer and antibody design

New classification of leukaemia subtypes reveals potential of existing drugs

New classification of leukaemia subtypes reveals potential of existing drugs

Suppressive immune cells' metabolic vulnerability may be targeted for cancer immunotherapy

Suppressive immune cells' metabolic vulnerability may be targeted for cancer immunotherapy

More from ecancer